Company Filing History:
10 out of 3,440 
10 out of 10 
1 out of 1 Years Active: 2016-2025
Title: Innovations by Wataru Akahata: Pioneering Alphavirus Research
Introduction
Wataru Akahata is an accomplished inventor based in Kensington, MD, who has contributed significantly to the field of medical research with a portfolio of 20 patents. His innovative work primarily focuses on the development of alphavirus replicon particles and virus-like particles, which hold promise in the prevention and treatment of viral diseases.
Latest Patents
One of Akahata's notable inventions is the "Alphavirus replicon particle," which includes alphavirus structural proteins and a replicon comprising polynucleotides encoding essential non-structural proteins. This invention strategically alters specific amino acids in the viral envelope to enhance its efficacy.
Additionally, he has developed innovative "Virus-like particles and methods of use," which feature modified alphavirus and flavivirus virus-like particles. This invention outlines various methods and compositions for producing these modified particles, aimed at delivering therapeutic agents effectively to cells and improving treatment outcomes related to alphavirus and flavivirus-mediated diseases.
Career Highlights
Throughout his career, Akahata has made significant contributions while working for prestigious organizations such as the United States of America, as represented by the Secretary, Department of Health and Human Services, and VLP Therapeutics, LLC. His research and inventions have positioned him as a key figure in viral research and therapeutic development.
Collaborations
Akahata has collaborated with several talented professionals in his field, including Ryuji Ueno and Srinivas Rao. These collaborations have facilitated breakthrough advancements in his innovative projects and have broadened the impact of his research within the scientific community.
Conclusion
Wataru Akahata's innovative contributions to the fields of virology and therapeutic development underscore the importance of continuous research in combating viral diseases. With a strong portfolio of patents, he remains at the forefront of medical advancements, helping to pave the way for future innovations in viral treatment and prevention.